Article
Author(s):
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Phase II Trial Data Lead to FDA Breakthrough Therapy Designation for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer
ACT Brief Episode 4: New Data on Trial Delays, Hybrid Payment Models, and Managing Complexity
How Policy Changes Could Impact Vaccine Trials and Public Participation
ACT Brief Episode 3: Breaking Down Data Silos to Accelerate Clinical Trials
Embracing Proactive Multi-Indication Development for Metabolic Therapies
Phase II B-SUPREME Trial Launches for ALG-000184 in Chronic Hepatitis B